5 Stocks to Sell Now According to Billionaire Larry Robbins

04. Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN)

Number of Hedge Fund Holders as of Q2 2022: 58

Connecticut-based Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) is a biopharmaceutical business. The company reported losses per share of $3.82 for the second quarter of 2022 on August 5, missing market expectations by $1.57.

During Q2, Glenview Capital sold its entire stake of 158,301 shares of Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) valued at $18.770 million.